Supplementary Figure 1 from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

• DOI: 10.1158/2767-9764.22787702.v1
• Publication Date: 2023-05-10T13:53:35Z
• Authors: Payal D. Shah; Alexander C. Huang; Xiaowei Xu; Robert Orlowski; Ravi K. Amaravadi; Lynn M. Schuchter; Paul Zhang; Julia Tchou; Tina Matlawski; Amanda Cervini; Joanne Shea; Joan Gilmore; Lester Lledo; Karen Dengel; Amy Marshall; E. John Wherry; Gerald P. Linette; Andrea Brennan; Vanessa Gonzalez; Irina Kulikovskaya; Simon F. Lacey; Gabriela Plesa; Carl H. June; Robert H. Vonderh...; Tara C. Mitchell

<p>Supplementary Figure 1.: Representative immunohistochemical staining for Subject 74 with metastatic melanoma; lymph node biopsy. Panel A: pS6 prior to infusion; B: at post-infusion biopsy; C: Ki-67 D: biopsy.</p>